Ottawa- In a significant development for diabetes care, Health Canada has approved the first generic version of Ozempic, originally developed by Novo Nordisk. The newly approved version is manufactured by Dr. Reddy’s Laboratories, marking a major step toward more affordable treatment options. The approval is expected to intensify competition in the market for GLP-1 therapies, […]
The Impressive Times
